Austin Radiological Association
Undisclosed - Practice Partnership with Radiology Partners Exclusive Financial Advisor
TCR2 Therapeutics Inc.
$75 Million - Initial Public OfferingJoint Bookrunner
Xeris Pharmaceuticals, Inc.
$59 Million - Follow-OnJoint Bookrunner
HCIT / Shift to Value “Stronger than Ever” According to KLAS; MDRX Still Challenged
Healthcare / 2019 Outlook: Macro Visibility Poor, It’s a Stockpicker’s Year in Healthcare
ADMS / Using Drug Delivery Tech to Make Better Drugs; Initiating ADMS with OP